Data / Form D filings / DVS Sciences, Inc.
DVS Sciences, Inc.: Form D filing
DVS Sciences, Inc., a biotechnology company in Richmond Hill, Ontario, Canada, filed a Form D with the SEC in 2011. The latest, on February 16, 2011, reports $4.1 million sold of a $14.8 million offering to 6 investors.
Find out what DVS Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 70 PENINSULA CRESCENT, Richmond Hill, Ontario, Canada, L4S 1
- Phone
- 1(416)946-8850
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1512982
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 16, 2011 | New notice | $14,797,741 | $4,131,828 | $10,665,913 | 6 | Dec 20, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Garry J. Nolan | Director | |
| Andrew J. Schwab | Director | |
| William Burkoth | Director | |
| Scott Tanner | Executive Officer, Director | |
| Neil J. Reid | Director | |
| Frank J. Witney | Director |
Every Form D from the week of Feb 14, 2011 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what DVS Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.